Practical insights for smarter strategy in the life sciences sector covering pharmaceutical, biotechnology, diagnostics, and medical devices areas for companies and investors. Get acquainted with state-of-the-art concepts and practices to make optimal decisions.
Finessing Pharma and Biotech Product Strategies in the Post-Inflation Reduction Act Era The recent passage of the Inflation Reduction Act (IRA) introduces sweeping changes for the biopharmaceutical industry through new…
A Value-Driven Commercialization Strategy for Pharmaceutical Assets An optimal commercialization strategy for pharmaceutical and biotechnology companies is vital for the value maximization of the company. Early-stage, as well as developed…